Pilkington V, et al. Meta-analysis of the risk of Grade 3/4 or serious clinical adverse events in 12 randomised trials of PrEP (n = 15,678). Abstract O143, HIV/Drug Therapy Glasgow 2018.
Het 2020 GOLD Science Committee-rapport over COVID-19 en COPD
mrt 2021 | COPD, Pneumonie, Virale infecties